Kornit Digital's Yaaqov Mann sells 1,665 shares
The shares sold were underlying RSUs granted July 11, 2024; the RSUs reported in that row are to be fully vested and settled by July 11, 2028.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kornit Digital Ltd. (KRNT) Chief Technology Officer Yaaqov Mann sold 1,665 ordinary shares on October 16, 2026, at a weighted average price of $17.03 per share under a Rule 10b5-1 trading plan. The report also lists directly held options to buy 3,279 ordinary shares at an exercise price of $18.80, expiring August 8, 2028, and options to buy 17,000 ordinary shares at an exercise price of $105.06, expiring January 31, 2032.
Insider Trade Summary 10b5-1
Net Seller: 1,665 shares
Net Sell
7 txns
Insider
Mann Yaaqov
Role
Chief Technology Officer
Sold
1,665 shs ($28K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F2 | 1,665 | $17.03 | $28K |
| holding | Stock Option (right to buy) F3, F8 | -- | -- | -- |
| holding | Stock Option (right to buy) F3, F8 | -- | -- | -- |
| holding | Ordinary Shares F3, F4 | -- | -- | -- |
| holding | Ordinary Shares F3, F5 | -- | -- | -- |
| holding | Ordinary Shares F3, F6 | -- | -- | -- |
| holding | Ordinary Shares F3, F7 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 62,220 shares (Direct);
Stock Option (right to buy) — 20,279 contracts (Direct)
Footnotes (8)
- F1. The price reported represents a weighted average price. The Reporting Person undertakes to provide to the SEC staff, upon request, full information regarding the number of shares and prices at which the transactions were effected.
- F2. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on July 11, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 96,774 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 96,774 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (July 11, 2028).
- F3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 9, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 9,559 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 9,559 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (March 9, 2027).
- F5. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 14, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 7,621 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 7,621 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (March 14, 2028).
- F6. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on July 11, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 7,752 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 7,752 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (July 11, 2028).
- F7. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 13, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the original 9,445 RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the original 9,445 RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row (which reflects a reduced number relative to the originally granted amount due to sales of underlying shares to date) will be fully vested and settled by the four-year anniversary of that grant date (March 13, 2029).
- F8. The options to purchase ordinary shares reported in this row are fully vested and became exercisable prior to the date of this report.
Key Figures
Ordinary shares sold: 1,665 shares
Weighted-average sale price: $17.03 per share
Shares underlying options: 3,279 ordinary shares
+3 more
6 metrics
Ordinary shares sold
1,665 shares
Sale on October 16, 2026
Weighted-average sale price
$17.03 per share
Sale on October 16, 2026
Shares underlying options
3,279 ordinary shares
Exercise price $18.80; expiration August 8, 2028
Option exercise price
$18.80 per share
Options covering 3,279 ordinary shares; expiration August 8, 2028
Shares underlying options
17,000 ordinary shares
Exercise price $105.06; expiration January 31, 2032
Option exercise price
$105.06 per share
Options covering 17,000 ordinary shares; expiration January 31, 2032
Key Terms
weighted average price, restricted share units, Rule 10b5-1 trading plan, fully vested
4 terms
weighted average price financial
"The price reported represents a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Rule 10b5-1 trading plan regulatory
"the sale was reported under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
fully vested financial
"The options to purchase ordinary shares reported in this row are fully vested"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What options did KRNT's Yaaqov Mann report holding?
Yaaqov Mann reported two directly held option positions, both fully vested and exercisable before the report date. One covers 3,279 ordinary shares at an $18.80 exercise price and expires August 8, 2028; the other covers 17,000 ordinary shares at a $105.06 exercise price and expires January 31, 2032.
AI-generated analysis. How Rhea-AI works. Not financial advice.
